Medherant
Latest round
- Series A
Last raised
- May 2019
Total raised
- $6.2M
Investors
- 1
About Medherant
Founded in 2015 in Coventry, UK, Medherant Limited focuses on developing transdermal drug delivery solutions.Medherant specializes in the creation of innovative transdermal drug delivery systems, chiefly through its proprietary TEPI Patch® technology. This advanced platform provides an effective and comfortable means of administering medications for various health concerns, particularly women’s health, pain management, and central nervous system (CNS) diseases. The TEPI Patch® allows drugs to permeate the skin, offering a non-invasive treatment option that enhances convenience and compliance.Medherant generates revenue through strategic partnerships and collaborations within the pharmaceutical sector, leveraging its TEPI Patch® technology for various applications. The company operates predominantly on a B2B model, focusing on licensing agreements and contract manufacturing arrangements with healthcare companies. Revenue is derived from upfront fees associated with licensing the TEPI Patch® technology, milestone payments linked to product development, and ongoing royalties based on sales of products incorporating Medherant’s technology. The company plans to expand its product lineup of transdermal solutions, although specific new products and release dates have not been disclosed. Additionally, Medherant aims to penetrate new geographical markets, particularly targeting Europe and North America for further expansion.
Who invested in Medherant
1 investor across 1 round
See all investors in Medherant
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 20, 2019
Amount
$6.2M
Investors
Questions about Medherant
Who invested in Medherant?
Medherant has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medherant raised?
Medherant has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Medherant last raise money?
Medherant's most recent round on record is a Series A, in May 2019.
What does Medherant do?
Founded in 2015 in Coventry, UK, Medherant Limited focuses on developing transdermal drug delivery solutions.
Where is Medherant headquartered?
Medherant is headquartered in Coventry, UK.
Which VCs invest in companies like Medherant?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Medherant's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Medherant? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.